In this work, we demonstrated that pharmacological inhibition of STING/TBK1 axis impaired bone marrow-derived fibroblasts activation, impeded macrophages to myofibroblasts transition, and protected against renal fibrosis development in folic acid (FA) nephropathy. The gene discussed is TBK1; the disease is renal fibrosis.